The Board voted to adopt changes to packaging and labeling rules as well as an interim policy for licensees to expedite implementation of the new rules and public comment drew remarks on WSLCB's lack of consideration for medical cannabis patients and consumer over-reliance on cannabis potency numbers.
The Policy and Rules Coordinator offered a look ahead at rulemaking actions and a recently received petition, and the Board will hear a presentation on opening up the agency's cannabis research collection.
The Committee learned about aggregate monthly retail sales figures for cannabis followed by a discussion of traceability identifiers and documentation of workarounds for problems with MJ Freeway's software.
The Board voted to expand an interim policy on quarantine, adopted two CR-102s on forfeiture and 2017 cannabis legislation rules, and passed a CR-101 to start a rule project on 2018 cannabis legislation rules.
Board members prepared for the next board meeting, heard about possible vapor regulatory and legislative changes, and discussed how to better incorporate research into the agency's rule development process.
Board members had an executive session on litigation against the agency, heard about progress towards implementing a retail license forfeiture program, and discussed a recent trip to Washington D.C. which included WSLCB leadership.